代谢综合征:流行病学,机制和当前的治疗方法
Benson M Hamooya1,2, Lukundo Siame1,2, Lweendo Muchaili1,2
1Department of Public Health, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Frontiers in nutrition
|September 19, 2025
概括
代谢综合征 (MetS) 通过诸如肥胖和胰岛素抵抗等因素显著增加心血管疾病 (CVD) 风险. 通过改变生活方式和服用药物来管理MetS对于预防心脏病至关重要.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 代谢综合征 (MetS) 是一组疾病,包括中心肥胖,脂质失调,高血压和胰岛素抵抗.
- 这些因素共同提高患心血管疾病 (CVD) 的风险.
- 由于其与心血管疾病的强烈关联,MetS构成了重大的公共卫生挑战.
研究的目的:
- 提供 MetS 与 CVD 联系的机制的全面概述.
- 探索相关因素和分子途径的相互作用.
- 突出管理METS对心血管健康的重要性.
主要方法:
- 这是一个复习文章.
- 它综合了现有的关于MetS和CVD的研究.
- 它检查了所涉及的分子通路和风险因素.
主要成果:
- 通过内皮功能障碍,动脉样硬化,氧化应激和炎症,MetS有助于心血管疾病.
- 失脂症,高血压和胰岛素抵抗是血管损伤的关键驱动因素.
- 慢性炎症和氧化应激加剧了这些过程.
结论:
- 通过生活方式干预 (体重控制,饮食,运动) 有效地管理MetS组件对于降低心血管疾病风险至关重要.
- 可能需要针对血糖,胆固醇和血压的药理干预措施.
- 提高认识和早期查对于公共卫生策略对抗MTS相关的CVD至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones
587
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
587
Overview of Carbohydrate Metabolism
3.3K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.3K


